Moreover, a more recent study using liver-specific SHP1 knockout (KO) mice revealed that SHP1 deficiency markedly improved obesity-linked NAFLD, which is possibly a result of reduced liver inflammation and hepatocellular damage [18]. This evidence concerns the gene PTPN6 and metabolic dysfunction-associated steatotic liver disease.